A 52-year-old man with diabetes mellitus presents to the emergency department with fever (39.2°C), hypotension (BP 88/54 mmHg), tachycardia (HR 118/min), and altered mental status. Blood cultures are pending. Lactate is 4.2 mmol/L. After fluid resuscitation and source control measures, which is the first-line antibiotic regimen for septic shock of presumed intra-abdominal origin?

## First-Line Empiric Therapy in Septic Shock **Key Point:** Piperacillin-tazobactam is the preferred empiric monotherapy for community-acquired intra-abdominal sepsis in non-severely immunocompromised patients without recent healthcare exposure. ### Rationale for Piperacillin-Tazobactam 1. **Spectrum Coverage** - Covers gram-negative aerobic bacteria (E. coli, Klebsiella, Proteus) - Covers gram-positive cocci (Streptococcus, some Staphylococcus) - Covers anaerobes (Bacteroides, Clostridium, Peptostreptococcus) - The tazobactam component inhibits β-lactamase-producing organisms 2. **Clinical Advantage** - Single agent eliminates need for combination therapy in community-acquired intra-abdominal infections - Excellent tissue penetration into peritoneal fluid and abdominal organs - Achieves bactericidal concentrations rapidly **High-Yield:** Sepsis bundles (Surviving Sepsis Campaign 2021) recommend broad-spectrum empiric antibiotics within 1 hour of recognition, with de-escalation once culture results available. ### When to Use Alternatives | Scenario | Preferred Agent | Reason | |----------|-----------------|--------| | Healthcare-associated infection / recent hospitalization | Carbapenem (imipenem or meropenem) | Risk of extended-spectrum β-lactamase (ESBL) | | Severe penicillin allergy | Fluoroquinolone + metronidazole or carbapenem | Avoid β-lactams | | Immunocompromised (neutropenic) | Carbapenem ± vancomycin ± aminoglycoside | Broader coverage for resistant gram-negatives | | Suspected MRSA (e.g., post-surgical, ICU) | Add vancomycin to piperacillin-tazobactam | Covers methicillin-resistant strains | **Clinical Pearl:** This patient has community-acquired sepsis (no mention of recent hospitalization or immunosuppression) with presumed intra-abdominal source—the classic indication for piperacillin-tazobactam monotherapy. **Tip:** Remember that carbapenems are reserved for resistant organisms or healthcare-associated infections to preserve their utility and prevent resistance emergence.